Ozan Pamir

Insider Reports History

Location
2443 Fillmore St #380 17649, San Francisco, CA
Signature
/s/ Jeong James Lee, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ozan Pamir:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Niagen Bioscience, Inc. Chief Financial Officer Common Stock 7.37K $50.2K $6.81 Nov 14, 2025 Direct
Niagen Bioscience, Inc. Chief Financial Officer Common Stock 2.22K $15.2K $6.85 Nov 14, 2025 The reported securities are held by the reporting person's spouse.
180 Life Sciences Corp. CFO Common Stock 8.98K $1.69K $0.19 Sep 4, 2023 Direct
ChromaDex Corp. Chief Financial Officer Employee Stock Options (right to buy) 17.2K Feb 12, 2025 Direct
180 Life Sciences Corp. CFO Stock Option (Right to Buy) 15K Sep 4, 2023 Direct

Insider Reports Filed by Ozan Pamir

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAGE Niagen Bioscience, Inc. Nov 14, 2025 2 $45.6K 4 Nov 17, 2025 Chief Financial Officer
CDXC ChromaDex Corp. Feb 12, 2025 1 $0 4 Feb 14, 2025 Chief Financial Officer
CDXC ChromaDex Corp. Nov 22, 2024 1 $21.4K 4 Nov 25, 2024 Chief Financial Officer
CDXC ChromaDex Corp. Oct 21, 2024 1 $0 4 Oct 23, 2024 Chief Financial Officer
CDXC ChromaDex Corp. Oct 21, 2024 0 $0 3 Oct 23, 2024 Chief Financial Officer
ATNF 180 Life Sciences Corp. Sep 4, 2023 1 $0 4 Sep 6, 2023 CFO
ATNF 180 Life Sciences Corp. May 18, 2023 1 $5.21K 4 May 19, 2023 CFO
ATNF 180 Life Sciences Corp. Dec 10, 2021 1 $14.7K 4 Dec 13, 2021 Interim CFO